Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
Abroad (travel likely)RecruitingPHASE3
Conditions
Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Chifeng Municipal Hospital, Chifeng, Mongolia, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China
Study leads
Jihui Hao, MD
Principal Investigator
Tianjin Medical University Cancer Institute and Hospital